Sign In
Buy ANIK
$14.41
+0.0300 (+0.209%)
At Close: Jun 03, 2026
Anika Therapeutics, Inc. (ANIK) Q3 2022 Earnings Call Transcript
08:31pm, Tuesday, 08'th Nov 2022
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q3 2022 Results Conference Call November 8, 2022 5:00 PM ET Company Participants Mark Namaroff - Vice President, Investor Relations, ESG and Corporate Communica
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
09:25am, Tuesday, 25'th Oct 2022
BEDFORD, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans
Anika Announces First Surgeries Performed Using the X-Twist™ Fixation System and Commences Limited Market Release
08:01pm, Monday, 12'th Sep 2022 GlobeNewswire Inc.
X-Twist expands Anika’s sports medicine portfolio with a cornerstone suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities X-Twist expands Anika’s sport
Anika Therapeutics Inc. (ANIK) CEO Cheryl Blanchard on Q2 2022 Results - Earnings Call Transcript
04:40am, Saturday, 06'th Aug 2022
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q2 2022 Earnings Conference Call August 3, 2022 5:00 PM ET Company Participants Mark Namaroff - Vice President, Investor Relations, ESG and Corporate Communicat
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
09:45pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Anika (ANIK) delivered earnings and revenue surprises of 23.08% and 8.95%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Anika Reports Second Quarter Fiscal 2022 Financial Results
08:05pm, Wednesday, 03'rd Aug 2022 GlobeNewswire Inc.
Second quarter revenue growth up 4%X-Twist™ 510(k) clearance received; Limited market release on schedule for 2H 2022
Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine
01:15pm, Wednesday, 27'th Jul 2022 GlobeNewswire Inc.
BEDFORD, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has
Apellis' (APLS) Geographic Atrophy NDA Gets Priority Review
04:06pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
The FDA accepts Apellis' (APLS) NDA for pegcetacoplan under a priority review for treating geographic atrophy secondary to age-related macular degeneration. A decision is due on Nov 26, 2022.
Acadia (ACAD) Files an NDA for Its Rett Syndrome Candidate
03:22pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
Acadia (ACAD) submits a new drug application to the FDA for trofinetide to treat Rett syndrome in patients aged two and older.
Ultragenyx (RARE) Provides Update From Angelman Syndrome Study
02:42pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
Ultragenyx (RARE) and GeneTx Biotherapeutics provide an update and positive interim data from the phase I/II study on GTX-102 for treating patients with Angelman syndrome.
Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022
09:05pm, Tuesday, 12'th Jul 2022 GlobeNewswire Inc.
BEDFORD, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company pla
Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022
05:05pm, Tuesday, 12'th Jul 2022
BEDFORD, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
01:27pm, Friday, 10'th Jun 2022 GlobeNewswire Inc.
BEDFORD, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
09:27am, Friday, 10'th Jun 2022
BEDFORD, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will p
Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio
11:00am, Friday, 20'th May 2022 GlobeNewswire Inc.
X-Twist provides a simple, versatile knotless suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities X-Twist provides a simple, versatile knotless suture anc
